Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation
- Status
- TERMINATED
- Phase
- PHASE3
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
- Status
- TERMINATED
- Phase
- NA
TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.
- Status
- WITHDRAWN
- Phase
- PHASE4
A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life
- Status
- COMPLETED
- Phase
- PHASE2
IFM 99-02 Thalidomide in Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Thalidomide to Patients With Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)
- Status
- TERMINATED
- Phase
- PHASE3
FREE Study - Fracture Reduction Evaluation
- Status
- COMPLETED
- Phase
- PHASE4
The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3